MetLife Investment Management’s Cross Country Healthcare CCRN Stock Holding History

MetLife Investment Management’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$114K	Sell	12,079 -1,521	-11%	-$13.6K	﹤0.01%	2483
2025 Q4	$110K	Sell	13,600 -971	-7%	-$10.6K	﹤0.01%	2555
2025 Q3	$207K	Sell	14,571 -3,710	-20%	-$49K	﹤0.01%	2298
2025 Q2	$239K	Buy	18,281 +884	+5%	+$12.1K	﹤0.01%	2095
2025 Q1	$259K	Sell	17,397 -1,925	-10%	-$33.1K	﹤0.01%	2061
2024 Q4	$351K	Hold	19,322	–	–	﹤0.01%	1986
2024 Q3	$260K	Hold	19,322	–	–	﹤0.01%	2151
2024 Q2	$267K	Buy	19,322 +1,932	+11%	+$30.6K	﹤0.01%	2065
2024 Q1	$326K	Hold	17,390	–	–	﹤0.01%	1919
2023 Q4	$394K	Hold	17,390	–	–	﹤0.01%	1827
2023 Q3	$431K	Hold	17,390	–	–	﹤0.01%	1717
2023 Q2	$488K	Sell	17,390 -1,504	-8%	-$37.3K	﹤0.01%	1706
2023 Q1	$422K	Hold	18,894	–	–	﹤0.01%	1750
2022 Q4	$502K	Sell	18,894 -801	-4%	-$26.1K	﹤0.01%	1645
2022 Q3	$559K	Hold	19,695	–	–	﹤0.01%	1561
2022 Q2	$410K	Hold	19,695	–	–	﹤0.01%	1807
2022 Q1	$427K	Buy	19,695 +7,206	+58%	+$156K	﹤0.01%	1866
2021 Q4	$347K	Buy	12,489 +2,121	+20%	+$51.4K	﹤0.01%	1713
2021 Q3	$220K	Sell	10,368 -3,984	-28%	-$74.7K	﹤0.01%	2026
2021 Q2	$237K	Hold	14,352	–	–	﹤0.01%	2045
2021 Q1	$179K	Buy	14,352 +8,900	+163%	+$94.4K	﹤0.01%	2112
2020 Q4	$48.4K	Buy	5,452 +2,871	+111%	+$23.4K	﹤0.01%	2254
2020 Q3	$16.8K	Sell	2,581 -13,914	-84%	-$88.2K	﹤0.01%	2286
2020 Q2	$102K	Hold	16,495	–	–	﹤0.01%	2248
2020 Q1	$111K	Hold	16,495	–	–	﹤0.01%	2013
2019 Q4	$192K	Hold	16,495	–	–	﹤0.01%	1999
2019 Q3	$170K	Hold	16,495	–	–	﹤0.01%	2036
2019 Q2	$155K	Hold	16,495	–	–	﹤0.01%	2177
2019 Q1	$116K	Hold	16,495	–	–	﹤0.01%	2260
2018 Q4	$121K	Hold	16,495	–	–	﹤0.01%	2198
2018 Q3	$144K	Hold	16,495	–	–	﹤0.01%	2263
2018 Q2	$186K	Hold	16,495	–	–	﹤0.01%	1949
2018 Q1	$183K	Hold	16,495	–	–	﹤0.01%	1935
2017 Q4	$210K	Buy	+16,495	New	+$218K	﹤0.01%	1908

Other funds holding CCRN

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

DIA

Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

MetLife Investment Management's CCRN Position: Q1 2026 in Review

MetLife Investment Management reduced its Cross Country Healthcare (CCRN) stake by 11% in Q1 2026, selling an estimated $13.6K and leaving 12,079 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #2483.

MetLife Investment Management first reported a position in CCRN in Q4 2017 and has held it in 34 quarters since. The position peaked at $559K in Q3 2022. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

MetLife Investment Management held 12,079 shares of Cross Country Healthcare worth $114K as of Q1 2026.
MetLife Investment Management sold 1,521 Cross Country Healthcare shares in Q1 2026, an estimated $13.6K.
Cross Country Healthcare made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2483 holding.
MetLife Investment Management first reported a position in Cross Country Healthcare in Q4 2017 and has held it in 34 quarters since.
MetLife Investment Management's Cross Country Healthcare position peaked at $559K in Q3 2022.
151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.